A drug dubbed CX717, made by Cortex Pharmaceuticals, Irvine, California, reverses the biological and behavioral effects of sleep deprivation, according to results of animal studies.
According to Dr. Boyle,
There is evidence that it is the low levels of performance in individuals particularly affected by sleep deprivation that are alleviated by CX717, and that this effect is seen with many measures of performance and across the whole dose range studied from 100 mg through 300 mg to 1000 mg.
